Movement Alert|MAO GEPING Rises 5.08% in Regular Trading, Beauty Sector Rallies as Institutions Remain Bullish Ahead of Interim Results

Market Focus08-10 14:16

On August 10, MAO GEPING rose 5.08% in regular trading, trading at HK$56.85/share, with turnover of HK$128 million.

On the news front, the beauty sector rallied broadly, with sector peers CHICMAX up 6.42% and GIANT BIOGENE up 4.36%, reflecting strong industry linkage. Bank of America Securities recently reiterated its Buy rating on MAO GEPING with a target price of HK$95, projecting first-half revenue growth exceeding 20% and net profit growth surpassing 30%, driven by an increasing share of higher-margin online channels. Management expects revenue growth to accelerate in the second half to achieve the full-year 30% target.

As the interim results window approaches, market optimism around earnings delivery is drawing capital inflows. The company reported full-year revenue of RMB 50.5 billion for the prior fiscal year with net profit growth of 36.8%, and multiple brokerages including Guotai Haitong and CICC have highlighted its strong brand momentum and unique positioning in Eastern aesthetics-inspired premium cosmetics.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment